Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
2-((2,6-Difluorobenzyl)(Ethoxycarbonyl)Amino)-4-((Dimethylamino)Methyl)-5-(4-Nitrophenyl)Thiophene-3-Carboxylic Acid is a chemical compound often recognized within professional pharmaceutical frameworks due to its BP, EP, and USP pharma grading. The compound stands out for its detailed molecular structure that combines fluorinated benzyl groups, ethoxycarbonyl moieties, and nitrophenyl-thiophene scaffolding, all embedding vital traits required in the pharmaceutical industry. Each functional group brings something important to the table, not only affecting reactivity but also driving solubility, stability, and safety profiles in real-world usage.
This substance presents a multifaceted molecular structure: it incorporates fluorine atoms on a benzyl ring, introducing both stability and metabolic resistance, alongside an ethoxycarbonyl group that supports lipophilicity. The molecule also features a nitrophenyl group linked directly to the thiophene core, reinforcing electron-withdrawing characteristics and increasing interactions during synthesis. Its formula expresses the convergence of these groups into a compound that often marks a pivotal step in advanced pharmaceutical research and development. A look at the structure reveals a substantial density and a significant molecular weight, giving insight into handling and storage choices. Chemical engineers pay special attention to these features because they determine everything from crystallization tendencies to powder flow in processing environments.
The compound appears in various solid forms, ranging from flakes and crystalline powders to rare pearls, depending on the conditions of purification and drying. Color tends to reflect the presence of the nitro functional group, with hues shifting toward pale yellow or off-white appearances. As a raw material, density becomes a real concern — both in bulk storage and compound formulation. Some batches demonstrate a dense crystalline form, while others show a more porous granule, impacting both mixing characteristics and solution preparation. When dissolved, the solution may show a slight color, and the preparation requires validated protocols, especially if strict BP, EP, or USP compliance is necessary. Stability under standard conditions is achieved with airtight containers in cool, low-light warehouses, preventing both decomposition and contamination. Scientists and quality control teams often study the melting point, solubility in ethanol, water, or dimethyl sulfoxide, and sensor-based moisture content to keep production within pharmacopeia specifications.
Under British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP) guidelines, manufacturers observe sharp standards for purity, assay results, residual solvents, and identification tests. These certifications impact which markets the compound enters and what regulatory demands are attached. Specifications typically mandate purity levels above 98%, with trace levels of related compounds controlled by validated analysis methods. Laboratories rely on established practices, such as high-performance liquid chromatography (HPLC), infrared (IR) spectroscopy, and melting point determination to confirm batch conformity. The material passes or fails based on clear benchmarks — it can’t support generic claims or rely on incomplete documentation. Each step from synthesis to quality assurance reflects the value of traceable, documented results that regulate entry to pharmaceutical supply chains. Batches get tagged with a Harmonized System (HS) Code, often 293499, for smooth transport and compliance through customs, which isn't a side detail but a critical checkpoint in global chemical logistics.
Anyone interacting with this compound in the lab or on the production floor needs strong chemical hygiene and risk awareness. Safety Data Sheets warn of moderate hazard: exposure to skin, eyes, or respiratory tissues can lead to irritation, and the compound's nitrophenyl content signals a need for extra caution, as nitroaromatic chemicals sometimes raise health concerns if not managed correctly. While not considered high-risk under standard safety codes, the compound calls for gloves, goggles, and fume hood usage to mitigate any chance of harm. Disposal routines follow regional chemical waste rules, focusing on avoiding release into water systems. Each pharmaceutical-grade batch also undergoes testing for residual solvents and heavy metals, to assure end-users that no hidden hazard escapes attention.
Compounds like 2-((2,6-Difluorobenzyl)(Ethoxycarbonyl)Amino)-4-((Dimethylamino)Methyl)-5-(4-Nitrophenyl)Thiophene-3-Carboxylic Acid stand at the intersection of scientific research and applied medical development. Their unique structures support the design of new drug candidates that might treat complex diseases—fields like oncology, infectious disease, or neurological disorders. Chemists select this raw material because elements like the difluorobenzyl ring can dramatically affect how a medicine interacts with protein targets or clears through metabolism. Small molecule research relies on such diversity to innovate, test, and adapt medicines beyond existing technologies. My experience in pharma development has shown how selecting a raw material with the right balance of physical properties speeds up formulation studies, but also helps avoid roadblocks in scaling and registration. No matter the project, success often hinges on choosing the clear, documented path through quality standards and regulatory logistics—a lesson repeated in small start-ups and big corporations alike.
Chengguan District, Lanzhou, Gansu, China
